Data / Form D filings / LabVoice Inc.
LabVoice Inc.: Form D filings
LabVoice Inc., a biotechnology company in Carrboro, NC, filed 3 Form D notices with the SEC between 2022 and 2026. The latest, on June 23, 2026, reports $1.2 million sold of a $1.2 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 252 SWEET BAY PLACE, Carrboro, NC, 27510
- Phone
- (786) 220-2010
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1951025
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Amendment | $1,200,000 | $1,200,000 | 4 | Nov 24, 2024 | sec.gov | |
| Apr 1, 2025 | New notice | $1,000,000 | $700,007 | $299,993 | 4 | Nov 24, 2024 | sec.gov |
| Oct 18, 2022 | New notice | $3,000,000 | $3,000,000 | 9 | Mar 7, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frederic Bost | Executive Officer, Director | |
| Mathew Hahn | Director | |
| Judy Ohrn Hicks | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LabVoice Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.